# White Mountains Insurance Group Ltd: financial statements, quarterly

WTM · NYSE · CIK 776867 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wtm.md) · [Financials](/companies/wtm/financials.md) · [Filings](/companies/wtm/filings.md) · [Insiders](/companies/wtm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wtm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [520](/filings/0000776867-24-000019.md) | [737 d](/filings/0001628280-26-012603.md) | [647](/filings/0000776867-25-000006.md) | [395](/filings/0000776867-25-000014.md) | [839](/filings/0001628280-25-049910.md) | [358 d](/filings/0001628280-26-012603.md) | [578](/filings/0001628280-26-030935.md) | [689](/filings/0001628280-26-053932.md) | [864](/filings/0001628280-25-049910.md) | [1,604 d](/filings/0001628280-26-012603.md) | [518](/filings/0001628280-26-030935.md) | [845](/filings/0001628280-26-053932.md) |
| Cost of revenue | $m | [8.0](/filings/0000776867-24-000019.md) | [6.9 d](/filings/0001628280-26-012603.md) | [7.6](/filings/0000776867-25-000006.md) | [7.0](/filings/0000776867-25-000014.md) | [7.6](/filings/0001628280-25-049910.md) | [7.4 d](/filings/0001628280-26-012603.md) | [7.5](/filings/0001628280-26-030935.md) | [42.4](/filings/0001628280-26-053932.md) | [55.3](/filings/0001628280-25-049910.md) | [46.6 d](/filings/0001628280-26-012603.md) | [42.7](/filings/0001628280-26-030935.md) | [80.1](/filings/0001628280-26-053932.md) |
| Interest expense | $m | [15.7](/filings/0000776867-24-000019.md) | [17.8 d](/filings/0001628280-26-012603.md) | [15.2](/filings/0000776867-25-000006.md) | [14.8](/filings/0000776867-25-000014.md) | [16.7](/filings/0001628280-25-049910.md) | [14.1 d](/filings/0001628280-26-012603.md) | [17.8](/filings/0001628280-26-030935.md) | [18.6](/filings/0001628280-26-053932.md) | [19.9](/filings/0001628280-25-049910.md) | [22.1 d](/filings/0001628280-26-012603.md) | [19.3](/filings/0001628280-26-030935.md) | [19.8](/filings/0001628280-26-053932.md) |
| Income tax | $m | [7.3](/filings/0000776867-24-000019.md) | [(34.9) d](/filings/0001628280-26-012603.md) | [10.8](/filings/0000776867-25-000006.md) | [6.5](/filings/0000776867-25-000014.md) | [11.6](/filings/0001628280-25-049910.md) | [3.7 d](/filings/0001628280-26-012603.md) | [9.6](/filings/0001628280-26-030935.md) | [12.9](/filings/0001628280-26-053932.md) | [17.1](/filings/0001628280-25-049910.md) | [87.3 d](/filings/0001628280-26-012603.md) | [0.8](/filings/0001628280-26-030935.md) | [24.8](/filings/0001628280-26-053932.md) |
| Net income | $m | [23.6](/filings/0000776867-24-000019.md) | [287 d](/filings/0001628280-26-012603.md) | [236](/filings/0000776867-25-000006.md) | [(54.6)](/filings/0000776867-25-000014.md) | [179](/filings/0001628280-25-049910.md) | [(130) d](/filings/0001628280-26-012603.md) | [33.9](/filings/0001628280-26-030935.md) | [123](/filings/0001628280-26-053932.md) | [114](/filings/0001628280-25-049910.md) | [836 d](/filings/0001628280-26-012603.md) | [(27.2)](/filings/0001628280-26-030935.md) | [200](/filings/0001628280-26-053932.md) |
| Diluted EPS | $ per share | [9.19](/filings/0000776867-24-000019.md) | not reported | [92.33](/filings/0000776867-25-000006.md) | [(21.24)](/filings/0000776867-25-000014.md) | [69.68](/filings/0001628280-25-049910.md) | not reported | [13.19](/filings/0001628280-26-030935.md) | [47.75](/filings/0001628280-26-053932.md) | [44.18](/filings/0001628280-25-049910.md) | not reported | [(12.59)](/filings/0001628280-26-030935.md) | [80.58](/filings/0001628280-26-053932.md) |
| Basic EPS | $ per share | [9.19](/filings/0000776867-24-000019.md) | not reported | [92.33](/filings/0000776867-25-000006.md) | [(21.24)](/filings/0000776867-25-000014.md) | [69.68](/filings/0001628280-25-049910.md) | not reported | [13.19](/filings/0001628280-26-030935.md) | [47.75](/filings/0001628280-26-053932.md) | [44.18](/filings/0001628280-25-049910.md) | not reported | [(12.59)](/filings/0001628280-26-030935.md) | [80.58](/filings/0001628280-26-053932.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [8.1](/filings/0000776867-23-000017.md) | [8.4](/filings/0000776867-25-000003.md) | [9.6](/filings/0000776867-24-000010.md) | [10.2](/filings/0000776867-24-000015.md) | [10.3](/filings/0000776867-24-000019.md) | [9.9](/filings/0001628280-26-012603.md) | [11.0](/filings/0000776867-25-000006.md) | [11.8](/filings/0000776867-25-000014.md) | [12.3](/filings/0001628280-25-049910.md) | [12.3](/filings/0001628280-26-053932.md) | [13.2](/filings/0001628280-26-030935.md) | [13.8](/filings/0001628280-26-053932.md) |
| Total liabilities | $bn | [4.0](/filings/0000776867-23-000017.md) | [3.8](/filings/0000776867-25-000003.md) | [4.7](/filings/0000776867-24-000010.md) | [5.3](/filings/0000776867-24-000015.md) | [5.1](/filings/0000776867-24-000019.md) | [4.8](/filings/0001628280-26-012603.md) | [5.9](/filings/0000776867-25-000006.md) | [6.5](/filings/0000776867-25-000014.md) | [6.6](/filings/0001628280-25-049910.md) | [6.1](/filings/0001628280-26-053932.md) | [7.0](/filings/0001628280-26-030935.md) | [7.5](/filings/0001628280-26-053932.md) |
| Long-term debt | $bn | [0.6](/filings/0000776867-23-000017.md) | [0.6](/filings/0000776867-25-000003.md) | [0.5](/filings/0000776867-24-000010.md) | [0.5](/filings/0000776867-24-000015.md) | [0.5](/filings/0000776867-24-000019.md) | [0.6](/filings/0001628280-26-012603.md) | [0.7](/filings/0000776867-25-000006.md) | [0.7](/filings/0000776867-25-000014.md) | [0.9](/filings/0001628280-25-049910.md) | [0.8](/filings/0001628280-26-053932.md) | [0.8](/filings/0001628280-26-030935.md) | [0.9](/filings/0001628280-26-053932.md) |
| Shareholders' equity | $bn | [3.9](/filings/0000776867-23-000017.md) | [4.2](/filings/0000776867-25-000003.md) | [4.5](/filings/0000776867-24-000010.md) | [4.4](/filings/0000776867-24-000015.md) | [4.6](/filings/0000776867-24-000019.md) | [4.5](/filings/0001628280-26-012603.md) | [4.5](/filings/0000776867-25-000006.md) | [4.6](/filings/0000776867-25-000014.md) | [4.8](/filings/0001628280-25-049910.md) | [5.4](/filings/0001628280-26-053932.md) | [5.4](/filings/0001628280-26-030935.md) | [5.4](/filings/0001628280-26-053932.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [223 d](/filings/0000776867-24-000019.md) | [24.5 d](/filings/0001628280-26-012603.md) | [36.5](/filings/0000776867-25-000006.md) | [217 d](/filings/0000776867-25-000014.md) | [269 d](/filings/0001628280-25-049910.md) | [64.1 d](/filings/0001628280-26-012603.md) | [(40.2)](/filings/0001628280-26-030935.md) | [178 d](/filings/0001628280-26-053932.md) | [359 d](/filings/0001628280-25-049910.md) | [53.9 d](/filings/0001628280-26-012603.md) | [30.5](/filings/0001628280-26-030935.md) | [(55.5) d](/filings/0001628280-26-053932.md) |
| Dividends paid | $m | [0.0 d](/filings/0000776867-24-000019.md) | [0.0 d](/filings/0001628280-26-012603.md) | [2.5](/filings/0000776867-25-000006.md) | [0.0 d](/filings/0000776867-25-000014.md) | [0.0 d](/filings/0001628280-25-049910.md) | [0.0 d](/filings/0001628280-26-012603.md) | [2.6](/filings/0001628280-26-030935.md) | [0.0 d](/filings/0001628280-26-053932.md) | [0.0 d](/filings/0001628280-25-049910.md) | [0.0 d](/filings/0001628280-26-012603.md) | [2.4](/filings/0001628280-26-030935.md) | [0.0 d](/filings/0001628280-26-053932.md) |
| Share repurchases | $m | [0.0 d](/filings/0000776867-24-000019.md) | [0.0 d](/filings/0001628280-26-012603.md) | [8.1](/filings/0000776867-25-000006.md) | [0.0 d](/filings/0000776867-25-000014.md) | [0.0 d](/filings/0001628280-25-049910.md) | [(0.2) d](/filings/0001628280-26-012603.md) | [9.9](/filings/0001628280-26-030935.md) | [0.0 d](/filings/0001628280-26-053932.md) | [0.0 d](/filings/0001628280-25-049910.md) | [193 d](/filings/0001628280-26-012603.md) | [25.9](/filings/0001628280-26-030935.md) | [191 d](/filings/0001628280-26-053932.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,856](/filings/0000776867-23-000017.md) | [2,539](/filings/0000776867-24-000010.md) | [2,525](/filings/0000776867-24-000015.md) | [2,523](/filings/0000776867-24-000019.md) | [2,531](/filings/0000776867-25-000006.md) | [2,532](/filings/0000776867-25-000014.md) | [2,533](/filings/0001628280-25-049910.md) | [2,541](/filings/0001628280-26-030935.md) | [2,541](/filings/0001628280-26-053932.md) | [2,542](/filings/0001628280-25-049910.md) | [2,447](/filings/0001628280-26-030935.md) | [2,408](/filings/0001628280-26-053932.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,386,721 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053932.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.